Speaker illustration

Doctor Tom Kretzschmar

University hospital Jena, Jena (Germany)

Member of:

European Society of Cardiology

CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicity

Event: ESC Congress 2023

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Cardiotoxicity of drugs and other therapies

Thumbnail

Doxorubicin induced cardiotoxicity is mediated by increased CerS2 expression and ceramide accumulation in vitro and in vivo

Event: ESC Congress 2021 - The Digital Experience

Topic: Drugs, Drug Targets

Session: Basic science e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb